B8.036 Breast Path Flashcards
major prognostic factors of breast carcinoma
invasive or in situ disease distant mets lymph node mets -most important -sentinel lymph node tumor size locally advanced disease inflammatory carcinoma
clinical staging for breast carcinoma
T (primary tumor size)
N ( regional lymph nodes)
M ( distant metastasis)
minor prognostic factors for breast carcinoma
histological subtypes
tumor grade
-nuclear grade, tubule formation, mitotic rate
ER/PR/Her2/neu
ER/PR/Her2/neu general prognostic indications
ER and PR + slightly better
overexpression of her2/neu = poor
predicts response to hormonal therapy
ER+
Her2-
low proliferation
luminal A
40-55% of breast cancers
older women
respond well to hormonal therapy
ER+
Her2-
high proliferation
luminal B
10% of breast cancers
associated with BRCA2 germline mutations
may respond to chemo
Her2+
half ER+, half ER-
20% of breast cancers
young women
respond to targeted therapy (herceptin)
ER-
Her2-
15% of breast cancers
more common in young women, AA, and hispanic
may be associated with BRCA1 mutation
may respond to chemo